Key Sessions
Isa Prada
You Report to Legal. What’s To Come?
PTC Therapeutics
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Agenda for Day Two - Wednesday April 28, 2027 - ET (Eastern Time, GMT-05:00)
keyboard_arrow_leftSearch & Filter
close
Streams
Formats
Agenda for Day Two - Wednesday April 28, 2027 - ET (Eastern Time, GMT-05:00)
close
Streams
Formats
Showing 1 of 1 Streams
General Session
8:30am - 9:00am
DOJ Special Address - Inside the New Fraud Division
- How the Fraud Division's creation and the realignment of personnel and FDCA expertise is reshaping enforcement priorities for life sciences
- What the Department's new posture on corporate enforcement, whistleblowers and self-disclosure signals for compliance programs going forward
- A look at where policy is headed next, and what pharmaceutical compliance leaders should be watching
- Jacob Foster - Deputy Assistant Attorney General, U.S. Department of Justice, Member, Attorney General's Super Intelligence Task Force
Showing 1 of 1 Streams
General Session
11:00am - 11:45am
Global Harmonization Under Pressure - Navigating Divergent Enforcement, Privacy and Regional Risk
Global enforcement has returned with a sharp, localized focus. Compliance and legal executives must design a unified compliance framework that withstands heavy DOJ and international pressure while satisfying conflicting regional mandates.
- Analyze the DOJ’s sharp FCPA focus and manufacturing hub exposure alongside China's stringent anti-corruption and anti-monopoly guidelines
- Navigate the friction between cross-border data transfers, localized data residency mandates, and evolving privacy laws across the US, EU, APAC, and LATAM
- Implement practical strategies to maintain a consistent global compliance framework that stays agile enough to absorb changing local regulatory demands
- Scott Hollander - Head, North America Litigation and Governmental Investigations, and Compliance Counsel, Dr.Reddy's Laboratories
- Itzy Wallace - Vice President, Head of Compliance & Risk, Mayne Pharma
- Monica Gutierrez - Senior Compliance Officer of Mexico & Argentina & Chile, Stryker
Community Conversations - Hear from the experts. Then join the conversation. Open with a panel discussion led by expert perspectives, followed by a guided discussion where attendees will share experiences, ask questions, and benchmark approaches with peers. Come ready to listen, contribute and leave with practical insights from both the panel and the room.
Showing 1 of 1 Streams
[Community Conversation D]
5:10pm - 6:00pm
[Community Conversation] The Self-Disclosure Clock – Deciding Whether to Tell DOJ Before They Find Out
Panel (20 Minutes)
- Examine how DOJ Self-disclosure expectations affect internal investigations
- Navigate the tension between early disclosure and incomplete information
- Discuss compliance to legal communication and escalation when potential misconduct surfaces
Community Conversation (30 Minutes)
Join a guided discussion to compare how compliance and legal teams are approaching escalation, investigations and self-disclosure decisions
- David Ryan - Senior Vice President, Legal and Chief Compliance Officer., Ardelyx, Inc
- Scott Hollander - Head, North America Litigation and Governmental Investigations, and Compliance Counsel, Dr.Reddy's Laboratories
Filter
Streams
Formats
